申请人:Nippon Shinyaku Co., Ltd.
公开号:US04333933A1
公开(公告)日:1982-06-08
Novel 2-amino-4-nicotinoylamino-6-halogenophenyl-s-triazines and acid addition salts thereof, possessing strong anti-inflammatory action when the phenyl group is mono- or di-halogen substituted. The compounds are formulated into pharmaceutical compositions in bulk or dosage form, and are administered to humans and animals having inflammatory conditions or disorders until the same are reduced or overcome. The novel compounds are prepared by various procedures such as reacting a benzoguanamine which is halogen-substituted with an active derivative of nicotinic acid, and recovering the 2-amino-4-nicotinoylamino-6-halogenophenyl-s-triazines thus formed.
新型2-氨基-4-烟酰胺基-6-卤代苯基-s-三嗪和其酸盐加成物具有强烈的抗炎作用,当苯基单卤或双卤取代时效果更佳。这些化合物以批量或剂量形式制成制药组合物,并用于治疗患有炎症状况或疾病的人类和动物,直到症状减轻或克服。新型化合物可通过多种方法制备,例如将卤代苯基苯胍与烟酸的活性衍生物反应,然后回收形成的2-氨基-4-烟酰胺基-6-卤代苯基-s-三嗪。